Gene Symbol | Gene ID | Gene Info |
---|---|---|
Arid5b
|
ENSMUSG00000019947.9 | AT rich interactive domain 5B (MRF1-like) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr10_68090596_68090764 | Arid5b | 45946 | 0.134733 | -0.76 | 1.6e-11 | Click! |
chr10_68090864_68091015 | Arid5b | 45687 | 0.135522 | -0.71 | 9.8e-10 | Click! |
chr10_68090256_68090550 | Arid5b | 46223 | 0.133892 | -0.69 | 4.9e-09 | Click! |
chr10_68091933_68092100 | Arid5b | 44610 | 0.138834 | -0.61 | 6.9e-07 | Click! |
chr10_68229674_68229825 | Arid5b | 48972 | 0.150025 | -0.58 | 3.2e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_22849623_22849800 | 12.52 |
Gm26131 |
predicted gene, 26131 |
12225 |
0.31 |
chr1_3671269_3672324 | 12.43 |
Xkr4 |
X-linked Kx blood group related 4 |
298 |
0.89 |
chr3_4798553_4798746 | 12.16 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
59 |
0.98 |
chr3_17791455_17791660 | 12.08 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1600 |
0.36 |
chr8_6645698_6645874 | 11.90 |
Gm44909 |
predicted gene 44909 |
185192 |
0.03 |
chr8_55026049_55026477 | 10.37 |
Gm45264 |
predicted gene 45264 |
2138 |
0.23 |
chr7_25515728_25515984 | 9.83 |
Ceacam2 |
carcinoembryonic antigen-related cell adhesion molecule 2 |
21237 |
0.11 |
chr9_61872295_61872485 | 9.74 |
Gm19208 |
predicted gene, 19208 |
20686 |
0.19 |
chr7_25461379_25461653 | 9.72 |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 |
15188 |
0.1 |
chr5_74999059_74999549 | 9.72 |
Gm42577 |
predicted gene 42577 |
10238 |
0.14 |
chr2_40332678_40332877 | 9.64 |
Gm24467 |
predicted gene, 24467 |
34260 |
0.19 |
chr2_4041994_4042180 | 9.55 |
Gm2639 |
predicted gene 2639 |
10472 |
0.15 |
chr10_33623806_33623994 | 9.43 |
Clvs2 |
clavesin 2 |
296 |
0.52 |
chr13_34095941_34096108 | 9.36 |
Gm47065 |
predicted gene, 47065 |
6997 |
0.11 |
chr17_90593854_90594144 | 9.30 |
Nrxn1 |
neurexin I |
5157 |
0.27 |
chr2_115131879_115132212 | 9.23 |
Gm28493 |
predicted gene 28493 |
3505 |
0.33 |
chr11_93829394_93829739 | 9.02 |
Utp18 |
UTP18 small subunit processome component |
46577 |
0.14 |
chr6_134887018_134887333 | 8.98 |
Gpr19 |
G protein-coupled receptor 19 |
593 |
0.6 |
chr5_5507681_5507868 | 8.76 |
Cldn12 |
claudin 12 |
6675 |
0.17 |
chr2_146549110_146549768 | 8.69 |
4933406D12Rik |
RIKEN cDNA 4933406D12 gene |
6508 |
0.27 |
chr1_97540301_97541044 | 8.43 |
Gm37171 |
predicted gene, 37171 |
4776 |
0.29 |
chr18_16670145_16670314 | 8.17 |
Cdh2 |
cadherin 2 |
160 |
0.97 |
chr7_10495587_10495984 | 8.16 |
Zik1 |
zinc finger protein interacting with K protein 1 |
391 |
0.76 |
chr16_72772461_72772624 | 8.11 |
Robo1 |
roundabout guidance receptor 1 |
109338 |
0.08 |
chr7_39894653_39894804 | 7.96 |
Gm44992 |
predicted gene 44992 |
15882 |
0.18 |
chr16_43623692_43623859 | 7.92 |
Mir568 |
microRNA 568 |
16880 |
0.18 |
chr6_144313023_144313448 | 7.91 |
Sox5 |
SRY (sex determining region Y)-box 5 |
103667 |
0.08 |
chr6_28842333_28842923 | 7.90 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
6279 |
0.2 |
chr9_41377483_41377907 | 7.90 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1134 |
0.48 |
chr1_151801648_151802002 | 7.88 |
Edem3 |
ER degradation enhancer, mannosidase alpha-like 3 |
46365 |
0.12 |
chr18_69563166_69563317 | 7.86 |
Tcf4 |
transcription factor 4 |
94 |
0.98 |
chr6_147061739_147061930 | 7.85 |
Mrps35 |
mitochondrial ribosomal protein S35 |
583 |
0.66 |
chr13_83873251_83873402 | 7.78 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
17882 |
0.19 |
chr17_63145510_63145822 | 7.74 |
Gm25348 |
predicted gene, 25348 |
48666 |
0.16 |
chr5_111368637_111368923 | 7.73 |
Pitpnb |
phosphatidylinositol transfer protein, beta |
11389 |
0.16 |
chr17_90593394_90593597 | 7.68 |
Nrxn1 |
neurexin I |
4653 |
0.28 |
chr3_126723256_126723448 | 7.54 |
Gm42515 |
predicted gene 42515 |
14145 |
0.14 |
chr13_83724333_83724611 | 7.53 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3091 |
0.17 |
chr10_46718374_46718662 | 7.52 |
Gm19994 |
predicted gene, 19994 |
48374 |
0.16 |
chr17_90592728_90592972 | 7.41 |
Nrxn1 |
neurexin I |
4008 |
0.29 |
chr15_84531439_84531771 | 7.40 |
Rtl6 |
retrotransposon Gag like 6 |
26218 |
0.18 |
chr1_25892463_25892638 | 7.35 |
Gm9884 |
predicted gene 9884 |
61893 |
0.08 |
chr11_12415334_12415643 | 7.35 |
Cobl |
cordon-bleu WH2 repeat |
3344 |
0.36 |
chr7_18949429_18949793 | 7.34 |
Nova2 |
NOVA alternative splicing regulator 2 |
23723 |
0.07 |
chr2_106425459_106425618 | 7.28 |
Dcdc5 |
doublecortin domain containing 5 |
41851 |
0.18 |
chr13_83741584_83742060 | 7.26 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2959 |
0.16 |
chr13_46634221_46634398 | 7.22 |
Cap2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
5749 |
0.18 |
chr11_54303609_54304215 | 7.21 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
93 |
0.96 |
chr9_91350886_91351318 | 7.19 |
A730094K22Rik |
RIKEN cDNA A730094K22 gene |
149 |
0.92 |
chr9_90693284_90693632 | 7.18 |
Gm2497 |
predicted gene 2497 |
40066 |
0.15 |
chr10_9694226_9694377 | 7.14 |
Gm6150 |
predicted gene 6150 |
9579 |
0.15 |
chr8_34890619_34890939 | 7.09 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
628 |
0.77 |
chr2_62046438_62046654 | 6.90 |
Slc4a10 |
solute carrier family 4, sodium bicarbonate cotransporter-like, member 10 |
39 |
0.99 |
chr11_24129398_24130415 | 6.86 |
Bcl11a |
B cell CLL/lymphoma 11A (zinc finger protein) |
12473 |
0.15 |
chr14_21411188_21411393 | 6.82 |
Gm25864 |
predicted gene, 25864 |
39184 |
0.14 |
chr9_40242560_40242744 | 6.81 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
26565 |
0.11 |
chr17_90593146_90593352 | 6.79 |
Nrxn1 |
neurexin I |
4407 |
0.28 |
chr1_177322970_177323308 | 6.78 |
Gm38328 |
predicted gene, 38328 |
53787 |
0.11 |
chr18_25678184_25678915 | 6.74 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
35221 |
0.19 |
chr3_42892344_42892576 | 6.72 |
Gm38044 |
predicted gene, 38044 |
306861 |
0.01 |
chr8_125401477_125401784 | 6.66 |
Sipa1l2 |
signal-induced proliferation-associated 1 like 2 |
91080 |
0.09 |
chr13_90643930_90644265 | 6.62 |
Gm36966 |
predicted gene, 36966 |
10012 |
0.25 |
chr15_67245960_67246168 | 6.60 |
1700012I11Rik |
RIKEN cDNA 1700012I11 gene |
19295 |
0.25 |
chr17_91093353_91093577 | 6.52 |
Nrxn1 |
neurexin I |
394 |
0.81 |
chr10_17631009_17631189 | 6.50 |
Gm47771 |
predicted gene, 47771 |
27414 |
0.2 |
chr13_35502204_35502355 | 6.48 |
Gm48704 |
predicted gene, 48704 |
41623 |
0.16 |
chr16_34395247_34395418 | 6.40 |
Kalrn |
kalirin, RhoGEF kinase |
3223 |
0.39 |
chr2_158556753_158556937 | 6.39 |
Arhgap40 |
Rho GTPase activating protein 40 |
15108 |
0.13 |
chr16_77422519_77422863 | 6.33 |
9430053O09Rik |
RIKEN cDNA 9430053O09 gene |
871 |
0.45 |
chr12_117197141_117197317 | 6.31 |
Gm10421 |
predicted gene 10421 |
45578 |
0.17 |
chr9_94610676_94610827 | 6.27 |
Gm39404 |
predicted gene, 39404 |
18555 |
0.17 |
chr13_53941470_53941649 | 6.25 |
Gm34557 |
predicted gene, 34557 |
6771 |
0.18 |
chr6_33739442_33739593 | 6.23 |
Exoc4 |
exocyst complex component 4 |
38083 |
0.19 |
chr6_17796921_17797464 | 6.22 |
Gm26738 |
predicted gene, 26738 |
37993 |
0.12 |
chr5_111752795_111752998 | 6.18 |
E130006D01Rik |
RIKEN cDNA E130006D01 gene |
8804 |
0.17 |
chr3_17793443_17793892 | 6.16 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
253 |
0.9 |
chr8_90496198_90496380 | 6.13 |
Tox3 |
TOX high mobility group box family member 3 |
147946 |
0.04 |
chr14_103663064_103663215 | 6.10 |
Slain1 |
SLAIN motif family, member 1 |
1359 |
0.45 |
chrX_103532339_103532495 | 6.10 |
Gm9157 |
predicted gene 9157 |
2934 |
0.11 |
chr17_87676993_87677384 | 6.06 |
Msh2 |
mutS homolog 2 |
4579 |
0.24 |
chr1_176946555_176946734 | 6.04 |
Gm15423 |
predicted gene 15423 |
13933 |
0.13 |
chr17_70488761_70489033 | 6.02 |
Dlgap1 |
DLG associated protein 1 |
27125 |
0.25 |
chr5_9703464_9703615 | 6.01 |
Grm3 |
glutamate receptor, metabotropic 3 |
21631 |
0.21 |
chr12_56004549_56004776 | 6.01 |
Gm5183 |
predicted gene 5183 |
45871 |
0.13 |
chr9_26721857_26722044 | 6.00 |
Gm48393 |
predicted gene, 48393 |
9224 |
0.2 |
chr6_36645374_36645533 | 5.98 |
Gm2189 |
predicted gene 2189 |
5187 |
0.27 |
chr2_93957591_93957803 | 5.98 |
Gm13889 |
predicted gene 13889 |
496 |
0.74 |
chr5_5431890_5432041 | 5.94 |
Cdk14 |
cyclin-dependent kinase 14 |
11653 |
0.19 |
chr4_84032579_84032795 | 5.94 |
6030471H07Rik |
RIKEN cDNA 6030471H07 gene |
12192 |
0.25 |
chr16_24509582_24509735 | 5.88 |
Morf4l1-ps1 |
mortality factor 4 like 1, pseudogene 1 |
19736 |
0.22 |
chr9_14304360_14304549 | 5.87 |
Sesn3 |
sestrin 3 |
10108 |
0.15 |
chr3_97308509_97308802 | 5.85 |
Bcl9 |
B cell CLL/lymphoma 9 |
10738 |
0.19 |
chr9_37406672_37406823 | 5.84 |
Robo4 |
roundabout guidance receptor 4 |
4701 |
0.14 |
chr2_105611972_105612254 | 5.83 |
Paupar |
Pax6 upstream antisense RNA |
49230 |
0.11 |
chr15_25019653_25019899 | 5.82 |
Gm2824 |
predicted gene 2824 |
1382 |
0.54 |
chr8_93917847_93918490 | 5.81 |
Gm24159 |
predicted gene, 24159 |
15768 |
0.16 |
chr6_103381062_103381254 | 5.80 |
Gm44295 |
predicted gene, 44295 |
101172 |
0.07 |
chr1_93079597_93080373 | 5.76 |
Kif1a |
kinesin family member 1A |
2436 |
0.23 |
chr13_13638865_13639065 | 5.76 |
Lyst |
lysosomal trafficking regulator |
946 |
0.64 |
chr10_87036520_87036671 | 5.75 |
1700113H08Rik |
RIKEN cDNA 1700113H08 gene |
21450 |
0.15 |
chr18_64889173_64889343 | 5.73 |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
229 |
0.84 |
chr2_146300726_146300877 | 5.70 |
Gm14117 |
predicted gene 14117 |
4746 |
0.23 |
chr1_98048789_98048971 | 5.70 |
Gm24465 |
predicted gene, 24465 |
942 |
0.4 |
chr6_90495493_90495923 | 5.67 |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
9281 |
0.11 |
chr1_87709719_87709870 | 5.66 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
453 |
0.8 |
chr3_128546926_128547219 | 5.65 |
Gm22293 |
predicted gene, 22293 |
6700 |
0.28 |
chr13_83749857_83750036 | 5.59 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
11083 |
0.12 |
chr9_15721557_15721729 | 5.59 |
Slc36a4 |
solute carrier family 36 (proton/amino acid symporter), member 4 |
5245 |
0.22 |
chr5_42523495_42523716 | 5.57 |
Gm7181 |
predicted gene 7181 |
23191 |
0.28 |
chr14_75482334_75482951 | 5.57 |
Siah3 |
siah E3 ubiquitin protein ligase family member 3 |
26660 |
0.19 |
chr1_128471971_128472514 | 5.56 |
Gm23902 |
predicted gene, 23902 |
17798 |
0.13 |
chr13_84762090_84762241 | 5.51 |
Gm26913 |
predicted gene, 26913 |
71224 |
0.13 |
chr1_34665920_34666140 | 5.49 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
12158 |
0.12 |
chr13_99676100_99676277 | 5.47 |
Gm24471 |
predicted gene, 24471 |
16341 |
0.21 |
chrX_101740828_101740994 | 5.45 |
Cxcr3 |
chemokine (C-X-C motif) receptor 3 |
6642 |
0.12 |
chr16_77852087_77852674 | 5.44 |
Gm17333 |
predicted gene, 17333 |
5776 |
0.27 |
chr11_19554563_19554970 | 5.43 |
Gm12027 |
predicted gene 12027 |
73295 |
0.11 |
chr1_97849463_97849614 | 5.42 |
Pam |
peptidylglycine alpha-amidating monooxygenase |
8657 |
0.21 |
chr6_70714359_70714837 | 5.40 |
Gm30211 |
predicted gene, 30211 |
4476 |
0.15 |
chr13_83721535_83721983 | 5.40 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
378 |
0.8 |
chr4_65839396_65839998 | 5.40 |
Trim32 |
tripartite motif-containing 32 |
234448 |
0.02 |
chr3_119063263_119063539 | 5.39 |
Gm43410 |
predicted gene 43410 |
195157 |
0.03 |
chr12_79007436_79007661 | 5.39 |
Tmem229b |
transmembrane protein 229B |
79 |
0.97 |
chr11_31941716_31941901 | 5.38 |
4930524B15Rik |
RIKEN cDNA 4930524B15 gene |
23784 |
0.18 |
chr10_59090889_59091164 | 5.36 |
Sh3rf3 |
SH3 domain containing ring finger 3 |
10992 |
0.24 |
chr6_55791826_55792546 | 5.35 |
Itprid1 |
ITPR interacting domain containing 1 |
44709 |
0.18 |
chr1_118776283_118776434 | 5.35 |
Gm28467 |
predicted gene 28467 |
33778 |
0.18 |
chr4_140218420_140218728 | 5.34 |
Igsf21 |
immunoglobulin superfamily, member 21 |
28210 |
0.18 |
chr2_63183648_63183919 | 5.33 |
Kcnh7 |
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
387 |
0.93 |
chr13_110871237_110871388 | 5.33 |
Gm30839 |
predicted gene, 30839 |
10641 |
0.16 |
chr19_59006883_59007106 | 5.29 |
Shtn1 |
shootin 1 |
31291 |
0.15 |
chr7_84328775_84329025 | 5.28 |
Gm25790 |
predicted gene, 25790 |
5485 |
0.17 |
chr14_116784038_116784189 | 5.27 |
Gm38045 |
predicted gene, 38045 |
33898 |
0.25 |
chr18_59061902_59062053 | 5.27 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
271 |
0.95 |
chr18_30509304_30509455 | 5.26 |
Gm7936 |
predicted pseudogene 7936 |
14006 |
0.19 |
chr4_124265824_124265975 | 5.25 |
Gm37667 |
predicted gene, 37667 |
13278 |
0.17 |
chr18_73096635_73097020 | 5.25 |
Gm31908 |
predicted gene, 31908 |
175737 |
0.03 |
chr11_32087496_32088333 | 5.25 |
Gm12108 |
predicted gene 12108 |
13314 |
0.2 |
chr5_133453505_133453656 | 5.22 |
Gm42625 |
predicted gene 42625 |
10238 |
0.23 |
chrX_49288183_49288615 | 5.21 |
Enox2 |
ecto-NOX disulfide-thiol exchanger 2 |
140 |
0.97 |
chr1_165018316_165018467 | 5.20 |
Gm26042 |
predicted gene, 26042 |
5954 |
0.2 |
chr10_108133791_108134149 | 5.20 |
Gm47999 |
predicted gene, 47999 |
8462 |
0.25 |
chr14_105851101_105851330 | 5.20 |
Gm48970 |
predicted gene, 48970 |
11286 |
0.21 |
chr12_29095988_29096385 | 5.20 |
4833405L11Rik |
RIKEN cDNA 4833405L11 gene |
10551 |
0.23 |
chr7_87186850_87187049 | 5.19 |
Gm6230 |
predicted gene 6230 |
55936 |
0.12 |
chr9_10268927_10269106 | 5.19 |
Gm24496 |
predicted gene, 24496 |
21571 |
0.22 |
chr17_59955724_59955911 | 5.17 |
Gm49853 |
predicted gene, 49853 |
100600 |
0.08 |
chr15_10655238_10655729 | 5.16 |
Gm10389 |
predicted gene 10389 |
55146 |
0.1 |
chr5_120408930_120409318 | 5.16 |
Lhx5 |
LIM homeobox protein 5 |
22575 |
0.12 |
chr10_37315161_37315370 | 5.16 |
Gm26535 |
predicted gene, 26535 |
22221 |
0.23 |
chr5_41942292_41942443 | 5.15 |
Gm20156 |
predicted gene, 20156 |
6695 |
0.25 |
chr13_83872958_83873152 | 5.14 |
2810049E08Rik |
RIKEN cDNA 2810049E08 gene |
18153 |
0.19 |
chr19_30153851_30154040 | 5.14 |
Rpl31-ps20 |
ribosomal protein L31, pseudogene 20 |
6675 |
0.2 |
chr10_58227289_58228680 | 5.14 |
Gm10807 |
predicted gene 10807 |
667 |
0.56 |
chr13_116575625_116575931 | 5.12 |
Gm47913 |
predicted gene, 47913 |
87758 |
0.08 |
chr10_102238597_102238748 | 5.12 |
Mgat4c |
MGAT4 family, member C |
79593 |
0.1 |
chr12_117054555_117054730 | 5.11 |
Gm10421 |
predicted gene 10421 |
96573 |
0.08 |
chr6_10969635_10970167 | 5.09 |
AA545190 |
EST AA545190 |
4477 |
0.3 |
chr11_22017536_22017834 | 5.09 |
Otx1 |
orthodenticle homeobox 1 |
14788 |
0.25 |
chr1_173366946_173367141 | 5.08 |
Cadm3 |
cell adhesion molecule 3 |
590 |
0.7 |
chr15_58976304_58977052 | 5.05 |
Mtss1 |
MTSS I-BAR domain containing 1 |
4139 |
0.18 |
chr12_26802654_26802851 | 5.04 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
32107 |
0.23 |
chr13_29015675_29016011 | 5.04 |
A330102I10Rik |
RIKEN cDNA A330102I10 gene |
450 |
0.87 |
chr8_30151290_30151449 | 5.04 |
Gm39154 |
predicted gene, 39154 |
30155 |
0.19 |
chr3_146769647_146769812 | 5.04 |
Prkacb |
protein kinase, cAMP dependent, catalytic, beta |
532 |
0.77 |
chr1_118911428_118911596 | 5.01 |
Mir6346 |
microRNA 6346 |
42708 |
0.16 |
chr14_24644159_24644310 | 5.00 |
4930428N03Rik |
RIKEN cDNA 4930428N03 gene |
22075 |
0.19 |
chr1_157746639_157746820 | 5.00 |
Gm38213 |
predicted gene, 38213 |
124593 |
0.05 |
chr9_15421773_15422369 | 4.99 |
Gm2517 |
predicted gene 2517 |
2543 |
0.17 |
chr7_29315231_29315516 | 4.97 |
Dpf1 |
D4, zinc and double PHD fingers family 1 |
310 |
0.82 |
chr4_57436348_57436547 | 4.97 |
Pakap |
paralemmin A kinase anchor protein |
2200 |
0.28 |
chr2_180952971_180953169 | 4.97 |
Nkain4 |
Na+/K+ transporting ATPase interacting 4 |
1249 |
0.24 |
chr12_52699206_52699547 | 4.97 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
7 |
0.98 |
chr7_51662439_51662822 | 4.95 |
Gm45072 |
predicted gene 45072 |
30905 |
0.14 |
chr3_154385878_154386340 | 4.92 |
AI606473 |
expressed sequence AI606473 |
54112 |
0.13 |
chr9_41078112_41078514 | 4.92 |
Ubash3b |
ubiquitin associated and SH3 domain containing, B |
1193 |
0.46 |
chr1_42704519_42704707 | 4.91 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
3439 |
0.17 |
chr6_60829687_60829904 | 4.91 |
Snca |
synuclein, alpha |
60 |
0.98 |
chrX_22950996_22951173 | 4.90 |
Gm26131 |
predicted gene, 26131 |
89148 |
0.1 |
chr14_79772053_79772375 | 4.90 |
Pcdh8 |
protocadherin 8 |
902 |
0.49 |
chr2_79048001_79048199 | 4.89 |
Gm14469 |
predicted gene 14469 |
9366 |
0.22 |
chr13_99397251_99397560 | 4.88 |
6430562O15Rik |
RIKEN cDNA 6430562O15 gene |
15216 |
0.18 |
chr6_55454639_55454790 | 4.87 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
2537 |
0.31 |
chr15_10655748_10655899 | 4.87 |
Gm10389 |
predicted gene 10389 |
55486 |
0.1 |
chr4_81415230_81415509 | 4.86 |
Mpdz |
multiple PDZ domain protein |
5873 |
0.27 |
chr5_112228050_112228579 | 4.86 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
327 |
0.82 |
chr2_52558532_52558705 | 4.86 |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
51 |
0.98 |
chr12_49381251_49381427 | 4.85 |
Gm34304 |
predicted gene, 34304 |
546 |
0.61 |
chr15_43803537_43803703 | 4.84 |
Gm2140 |
predicted gene 2140 |
4841 |
0.32 |
chr9_91379182_91379441 | 4.83 |
Zic4 |
zinc finger protein of the cerebellum 4 |
669 |
0.54 |
chr6_92347726_92347877 | 4.83 |
Gm44024 |
predicted gene, 44024 |
66408 |
0.1 |
chr14_38629729_38629940 | 4.82 |
Gm20641 |
predicted gene 20641 |
107785 |
0.08 |
chr13_113917716_113918082 | 4.82 |
Arl15 |
ADP-ribosylation factor-like 15 |
123277 |
0.05 |
chr13_84285645_84285831 | 4.82 |
Gm46432 |
predicted gene, 46432 |
3922 |
0.2 |
chr5_90987721_90988058 | 4.81 |
Epgn |
epithelial mitogen |
39575 |
0.11 |
chr1_157969609_157969781 | 4.81 |
Gm38256 |
predicted gene, 38256 |
29310 |
0.25 |
chr11_96893520_96893681 | 4.80 |
Cdk5rap3 |
CDK5 regulatory subunit associated protein 3 |
15158 |
0.08 |
chr9_41697271_41698297 | 4.78 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr7_40901199_40901451 | 4.77 |
A230077H06Rik |
RIKEN cDNA A230077H06 gene |
388 |
0.72 |
chr13_84905042_84905193 | 4.75 |
Gm4059 |
predicted gene 4059 |
69200 |
0.12 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.5 | 31.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.9 | 11.7 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
2.1 | 6.2 | GO:0021553 | olfactory nerve development(GO:0021553) |
2.0 | 6.0 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.8 | 5.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.8 | 7.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.6 | 13.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.6 | 9.5 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.5 | 4.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.5 | 4.4 | GO:0021856 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.5 | 7.3 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.4 | 8.6 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.4 | 4.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.3 | 4.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.3 | 4.0 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.3 | 6.5 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.3 | 3.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.2 | 3.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.2 | 3.6 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.2 | 7.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
1.1 | 4.6 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
1.1 | 5.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.1 | 3.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.1 | 3.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.1 | 3.2 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
1.0 | 1.0 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
1.0 | 3.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.0 | 3.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.0 | 5.0 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
1.0 | 3.0 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
1.0 | 4.8 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.9 | 6.6 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.9 | 7.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.9 | 2.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.9 | 2.7 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.9 | 0.9 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.9 | 2.6 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.9 | 3.5 | GO:0099612 | protein localization to axon(GO:0099612) |
0.8 | 6.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.8 | 11.0 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.8 | 1.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.8 | 0.8 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.8 | 2.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.8 | 3.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.8 | 5.5 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.8 | 3.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.8 | 2.3 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.8 | 2.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.8 | 2.3 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.8 | 2.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.8 | 4.5 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
0.7 | 1.5 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.7 | 6.7 | GO:0071625 | vocalization behavior(GO:0071625) |
0.7 | 5.8 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.7 | 0.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 2.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.7 | 2.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.7 | 2.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.7 | 2.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.7 | 2.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.7 | 2.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.7 | 3.5 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.7 | 2.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.7 | 6.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.7 | 2.1 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.7 | 2.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.7 | 2.1 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.7 | 15.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.7 | 3.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.7 | 5.4 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.7 | 0.7 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.7 | 1.4 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.7 | 2.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.7 | 2.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.7 | 1.3 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.7 | 2.0 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.7 | 11.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.7 | 2.0 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.6 | 1.3 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.6 | 1.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.6 | 3.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.6 | 2.6 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.6 | 2.5 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.6 | 1.9 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.6 | 1.9 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.6 | 0.6 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.6 | 8.0 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.6 | 1.8 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.6 | 1.8 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.6 | 4.3 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.6 | 2.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.6 | 1.8 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.6 | 4.8 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.6 | 0.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.6 | 2.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.6 | 2.4 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.6 | 1.8 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.6 | 3.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.6 | 1.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.6 | 1.7 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.6 | 1.7 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.6 | 1.7 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.6 | 2.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.6 | 1.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.6 | 2.3 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.6 | 2.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.6 | 3.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.6 | 1.7 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.5 | 1.6 | GO:0030070 | insulin processing(GO:0030070) |
0.5 | 0.5 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.5 | 1.1 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 2.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.5 | 8.5 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.5 | 2.1 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 2.6 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.5 | 1.0 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.5 | 3.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.5 | 1.5 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.5 | 2.0 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.5 | 1.5 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.5 | 0.5 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.5 | 3.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.5 | 0.5 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.5 | 2.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 2.5 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.5 | 0.5 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.5 | 1.9 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.5 | 3.4 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.5 | 2.9 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.5 | 3.3 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.5 | 0.5 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.5 | 1.4 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.5 | 2.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 1.4 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.5 | 3.2 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.5 | 2.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.5 | 0.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.5 | 1.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.5 | 1.8 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.4 | 3.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.4 | 1.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 2.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.4 | 0.4 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.4 | 6.1 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.4 | 3.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.4 | 0.4 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.4 | 1.3 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.4 | 0.9 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.4 | 2.6 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.4 | 1.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.4 | 2.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.4 | 1.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.4 | 2.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.4 | 5.5 | GO:0001964 | startle response(GO:0001964) |
0.4 | 2.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.4 | 2.5 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.4 | 1.2 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.4 | 1.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.4 | 1.6 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.4 | 0.4 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.4 | 2.4 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.4 | 0.8 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.4 | 1.2 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.4 | 2.0 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.4 | 0.8 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.4 | 1.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.4 | 0.4 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.4 | 1.2 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.4 | 6.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.4 | 6.7 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.4 | 2.3 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.4 | 1.5 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.4 | 1.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.4 | 0.4 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.4 | 0.4 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.4 | 12.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.4 | 1.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.4 | 1.9 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.4 | 1.5 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.4 | 1.1 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 1.1 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.4 | 1.1 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
0.4 | 3.6 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.4 | 1.1 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.4 | 1.1 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.4 | 2.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.4 | 0.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.4 | 0.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.4 | 1.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.4 | 0.7 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.4 | 2.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.4 | 1.8 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.4 | 2.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
0.3 | 1.7 | GO:0015808 | L-alanine transport(GO:0015808) |
0.3 | 0.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.3 | 3.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.3 | 4.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 3.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.3 | 1.0 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.3 | 1.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.3 | 1.3 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.3 | 1.3 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 1.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 2.0 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 1.7 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.3 | 1.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 1.3 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.3 | 0.7 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 1.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 0.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.3 | 2.0 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 2.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.3 | 25.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 0.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.3 | 0.3 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.3 | 0.3 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.3 | 0.9 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 0.9 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 1.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 0.9 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.3 | 0.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 0.3 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.3 | 4.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 0.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.3 | 1.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 1.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 0.3 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.3 | 2.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 0.9 | GO:0022038 | corpus callosum development(GO:0022038) |
0.3 | 1.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.3 | 0.6 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.3 | 0.3 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.3 | 0.6 | GO:0010042 | response to manganese ion(GO:0010042) |
0.3 | 4.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 0.9 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.3 | 1.2 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.3 | 0.3 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.3 | 1.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.3 | 0.3 | GO:0006901 | vesicle coating(GO:0006901) |
0.3 | 2.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.3 | 0.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 1.7 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.3 | 1.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 1.4 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.3 | 0.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 1.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.3 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) negative regulation of dopaminergic neuron differentiation(GO:1904339) |
0.3 | 1.1 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.3 | 1.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 0.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.3 | 1.4 | GO:0010165 | response to X-ray(GO:0010165) |
0.3 | 1.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 0.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 0.6 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.3 | 11.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 0.6 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.3 | 1.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 0.8 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 0.3 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.3 | 0.5 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 2.5 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.3 | 3.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.3 | 0.8 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 1.1 | GO:0002576 | platelet degranulation(GO:0002576) |
0.3 | 1.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 0.5 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.3 | 0.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.3 | 1.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 0.8 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.3 | 3.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.3 | 1.6 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.3 | 0.8 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.3 | 0.5 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.3 | 1.1 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.3 | 0.8 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.3 | 1.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 0.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.3 | 0.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.3 | 0.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 0.5 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.3 | 1.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 2.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.3 | 1.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 0.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 3.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 2.0 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.3 | 2.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 0.5 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.3 | 3.8 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 0.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 1.5 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 0.5 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 0.7 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.2 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.2 | 1.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 0.7 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.2 | 0.5 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.2 | 1.0 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 4.4 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.2 | 0.5 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 1.2 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 2.9 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.2 | 0.5 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.2 | 1.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 3.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 1.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 2.6 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.2 | 1.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.2 | 1.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.7 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 1.6 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 0.9 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.2 | 0.7 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.2 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.9 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.2 | 0.5 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 0.5 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.2 | 0.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 2.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.2 | 0.7 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.2 | 0.7 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 1.3 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
0.2 | 0.9 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 1.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 0.7 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.2 | 1.8 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.2 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 1.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.6 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 2.4 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.2 | 0.6 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.2 | 2.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 0.2 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.2 | 0.9 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 0.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.6 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.2 | 0.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 1.3 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.2 | 0.6 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 0.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 0.6 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.2 | 1.7 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.2 | 0.8 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 1.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.2 | 0.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 0.4 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.2 | 2.4 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.2 | 0.6 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.2 | 0.6 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.2 | 1.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 0.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.2 | 0.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 0.8 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 1.4 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.2 | 1.0 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.4 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 1.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 3.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.6 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 1.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 1.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 1.3 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.2 | 0.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.2 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.2 | 3.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.4 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 1.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.2 | 0.4 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.2 | 0.6 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 0.7 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 1.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.2 | 0.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.2 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 1.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 0.2 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 1.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 0.5 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.2 | 0.5 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.7 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.9 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 0.9 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.2 | 0.7 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 0.3 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.7 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 1.4 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.2 | 1.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 0.3 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.2 | 0.3 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.2 | 0.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 0.8 | GO:0034776 | response to histamine(GO:0034776) |
0.2 | 0.7 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 1.7 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.8 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 1.0 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.2 | 0.5 | GO:0009204 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
0.2 | 1.7 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 0.8 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 0.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.2 | 0.5 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.2 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.2 | 0.5 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.2 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.2 | 1.8 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.2 | 2.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 2.7 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.2 | 0.3 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.2 | 0.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 0.8 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 0.9 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.2 | 0.2 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.2 | 0.8 | GO:0015858 | nucleoside transport(GO:0015858) |
0.2 | 2.2 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.2 | 0.3 | GO:0072176 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.2 | 1.1 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.2 | 0.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 1.1 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.2 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.6 | GO:0036233 | glycine import(GO:0036233) |
0.2 | 0.6 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.2 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 0.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 0.5 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.1 | 0.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.3 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.1 | 0.3 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.1 | 1.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.9 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.6 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 1.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.3 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.1 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 15.3 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.6 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 0.4 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 1.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.3 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
0.1 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 1.0 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 1.0 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 2.2 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.1 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.5 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.8 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 2.2 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.1 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.1 | 1.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.3 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.9 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 0.1 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 0.3 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.4 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.1 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.1 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.6 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.2 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.1 | GO:0033483 | gas homeostasis(GO:0033483) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.6 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 1.0 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.1 | 0.7 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 0.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 1.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 2.8 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.4 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.1 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
0.1 | 1.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 0.1 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.1 | 0.6 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.3 | GO:0002855 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
0.1 | 2.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.2 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.8 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.1 | 0.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.2 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 2.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 1.3 | GO:0003407 | neural retina development(GO:0003407) |
0.1 | 2.0 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.4 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.2 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.1 | 0.2 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.7 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.7 | GO:0021756 | striatum development(GO:0021756) |
0.1 | 0.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.1 | 0.4 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.3 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 2.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.5 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.2 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 1.0 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.3 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.6 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.1 | 0.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.6 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.1 | 0.4 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.7 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.5 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.4 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.3 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.7 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 4.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.2 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.1 | 0.4 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.1 | 0.1 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.1 | 0.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.1 | 0.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 1.0 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.7 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 2.5 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.1 | 0.3 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 0.6 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.6 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 1.1 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.1 | 0.4 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.5 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.2 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 1.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.4 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.1 | 0.3 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.3 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 3.2 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.9 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.2 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 1.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.4 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.1 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.1 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.1 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.3 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.2 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.3 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.7 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.2 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.6 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.2 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.3 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 2.2 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.2 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.6 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 1.1 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.1 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.4 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.2 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.1 | 0.2 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.3 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 1.2 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.7 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.1 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.1 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.4 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.2 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
0.1 | 0.3 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.1 | 0.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.5 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.4 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.6 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 3.0 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.1 | 0.2 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.1 | 0.4 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.2 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.1 | 0.1 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.1 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.7 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.1 | GO:0045472 | response to ether(GO:0045472) |
0.1 | 0.5 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.9 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.1 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.1 | GO:0002019 | renin-angiotensin regulation of aldosterone production(GO:0002018) regulation of renal output by angiotensin(GO:0002019) |
0.1 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 1.5 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.1 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.8 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.1 | 0.5 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.2 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.1 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.1 | 0.2 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.1 | 2.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.2 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.1 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.1 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.5 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.2 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.2 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.0 | 0.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.0 | 0.3 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.7 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.1 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.0 | 0.1 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.0 | 0.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.3 | GO:0009209 | pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
0.0 | 0.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.2 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.0 | 0.5 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.1 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) |
0.0 | 0.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.0 | 0.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.0 | GO:0021564 | vagus nerve development(GO:0021564) |
0.0 | 0.0 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.1 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.0 | 0.0 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.0 | 0.0 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.0 | 0.0 | GO:1902564 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) negative regulation of neutrophil activation(GO:1902564) |
0.0 | 0.1 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.0 | 0.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.0 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.0 | 0.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.0 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.0 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.0 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.2 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.4 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.0 | 0.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.0 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.0 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.0 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.0 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.0 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.0 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.1 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.0 | 1.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 0.1 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.0 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.0 | 0.0 | GO:0086066 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.0 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.0 | 0.1 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.0 | 0.0 | GO:0060896 | neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) |
0.0 | 0.2 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.0 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.0 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.0 | 0.0 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) |
0.0 | 0.2 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.0 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.0 | 0.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.0 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.0 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.0 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.3 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.0 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.0 | 0.0 | GO:0051231 | spindle elongation(GO:0051231) |
0.0 | 0.2 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.4 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.0 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.0 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.0 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.0 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.0 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.6 | GO:0097441 | basilar dendrite(GO:0097441) |
1.7 | 5.0 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.5 | 4.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.5 | 4.4 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
1.2 | 2.5 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.2 | 11.1 | GO:0016342 | catenin complex(GO:0016342) |
1.1 | 4.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.0 | 4.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.0 | 3.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.9 | 4.6 | GO:0097433 | dense body(GO:0097433) |
0.9 | 9.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.9 | 5.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.9 | 6.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.8 | 3.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.8 | 5.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.8 | 1.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.8 | 4.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.8 | 2.4 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.8 | 4.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.8 | 2.3 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.8 | 3.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.8 | 6.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.7 | 35.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.7 | 6.3 | GO:0030673 | axolemma(GO:0030673) |
0.7 | 4.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.7 | 0.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.7 | 0.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.7 | 2.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.7 | 4.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.6 | 7.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.6 | 10.9 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.6 | 1.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.6 | 3.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 1.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.6 | 4.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.6 | 15.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.6 | 7.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.6 | 4.4 | GO:0005883 | neurofilament(GO:0005883) |
0.5 | 2.7 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.5 | 2.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.5 | 1.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.5 | 4.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.5 | 1.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 1.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.5 | 3.8 | GO:0071437 | invadopodium(GO:0071437) |
0.5 | 5.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.5 | 2.8 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.4 | 2.7 | GO:0002177 | manchette(GO:0002177) |
0.4 | 6.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 4.3 | GO:0060091 | kinocilium(GO:0060091) |
0.4 | 1.3 | GO:0036396 | MIS complex(GO:0036396) |
0.4 | 1.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 2.4 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.4 | 10.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.4 | 1.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 5.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.4 | 2.9 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.4 | 1.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 1.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 0.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 2.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 0.6 | GO:0030894 | replisome(GO:0030894) |
0.3 | 2.8 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 2.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 0.6 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 0.9 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 0.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.3 | 8.9 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 0.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 2.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.3 | 2.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 7.5 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.3 | 1.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.3 | 0.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 0.3 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.3 | 1.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 1.4 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 0.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 2.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 3.4 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 13.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 1.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 2.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 1.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 3.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.3 | 3.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.3 | 0.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.2 | 1.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 0.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 1.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 2.4 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 2.4 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.2 | 1.9 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 2.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 30.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 0.7 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 6.0 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 0.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 1.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 3.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 0.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 2.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 1.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 2.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.2 | 0.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 1.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 0.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 0.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 0.8 | GO:0032590 | dendrite membrane(GO:0032590) |
0.2 | 0.8 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 0.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.6 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 0.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 0.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 0.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 0.4 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 0.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 0.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 1.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.0 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 1.3 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.2 | 1.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.2 | 2.0 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 1.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 0.4 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 1.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 1.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 1.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 1.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.7 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 1.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 7.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.8 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.5 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 17.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.6 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 4.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 7.8 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.5 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 1.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 4.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.5 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.4 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 1.0 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 1.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 6.3 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.7 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 0.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 0.5 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 1.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.1 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.1 | 0.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.9 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 2.4 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 4.0 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 1.2 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.8 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 2.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.8 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 0.3 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.0 | 0.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.0 | 3.0 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 1.3 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 1.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 1.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.0 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.3 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.0 | 0.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.6 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.0 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
0.0 | 0.2 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.1 | GO:0032039 | integrator complex(GO:0032039) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 17.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.5 | 5.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.3 | 6.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.2 | 6.6 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.0 | 5.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.9 | 5.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.3 | 4.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.2 | 7.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.1 | 3.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.1 | 4.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.0 | 4.2 | GO:0051425 | PTB domain binding(GO:0051425) |
1.0 | 3.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.0 | 3.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.0 | 9.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.0 | 3.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.0 | 4.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.9 | 2.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.9 | 12.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.9 | 4.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.9 | 3.5 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.9 | 6.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.9 | 6.0 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.8 | 2.5 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.8 | 1.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.8 | 3.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.8 | 4.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.8 | 6.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.8 | 5.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.8 | 2.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.7 | 2.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.7 | 4.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.7 | 2.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.7 | 1.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.7 | 1.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.7 | 2.1 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.7 | 2.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.7 | 0.7 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.7 | 2.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 1.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.7 | 5.9 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.7 | 5.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.6 | 1.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.6 | 12.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.6 | 3.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.6 | 1.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.6 | 1.8 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.6 | 2.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.6 | 5.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.6 | 2.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.6 | 2.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.6 | 7.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.5 | 1.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.5 | 1.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.5 | 4.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.5 | 1.6 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.5 | 1.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.5 | 1.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.5 | 1.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 6.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.5 | 4.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.5 | 6.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.5 | 1.5 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.5 | 8.4 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.5 | 2.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.5 | 2.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 1.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.5 | 1.9 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.5 | 1.4 | GO:0005119 | smoothened binding(GO:0005119) |
0.5 | 4.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.5 | 3.7 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.5 | 3.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.5 | 2.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 1.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.5 | 2.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.5 | 3.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.5 | 1.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 3.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 1.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 2.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.4 | 0.9 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 1.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.4 | 3.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.4 | 1.7 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 1.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 1.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.4 | 1.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.4 | 1.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.4 | 2.4 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.4 | 1.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.4 | 5.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 0.8 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.4 | 1.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.4 | 1.9 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 2.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 1.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.4 | 1.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.4 | 1.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 1.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.4 | 1.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 1.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 0.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.3 | 1.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 0.7 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.3 | 0.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 1.7 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.3 | 2.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 2.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 3.0 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.3 | 2.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 1.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 1.3 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.3 | 1.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 0.6 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.3 | 2.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 2.5 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.3 | 4.1 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 1.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 2.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 1.5 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.3 | 0.9 | GO:0043918 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.3 | 2.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 0.6 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.3 | 1.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.3 | 4.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 3.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 0.9 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 2.1 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.3 | 1.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.3 | 0.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 1.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 0.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 2.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 0.9 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 2.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 2.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 0.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.3 | 1.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.3 | 1.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 1.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 0.8 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 2.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 0.8 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 0.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.3 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 0.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.3 | 0.3 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.3 | 0.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 3.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.3 | 1.0 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.3 | 3.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.3 | 1.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 3.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 2.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 1.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 1.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 5.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 1.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 0.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 1.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 5.2 | GO:0044688 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.2 | 1.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 0.7 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 2.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 2.8 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 0.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 4.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.6 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.2 | 0.7 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 0.7 | GO:0004103 | choline kinase activity(GO:0004103) |
0.2 | 3.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 4.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 1.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 6.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 1.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 0.2 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.2 | 0.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.2 | 0.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.6 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 3.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 1.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 0.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 0.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 3.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 0.6 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 0.4 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.2 | 2.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 2.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 0.8 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 1.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.8 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 0.9 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 3.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 6.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 4.6 | GO:0005272 | sodium channel activity(GO:0005272) |
0.2 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 1.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 4.1 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.2 | 1.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 1.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 2.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 0.5 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 0.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 1.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 2.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 4.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 0.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 0.2 | GO:0030352 | inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity(GO:0030351) inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity(GO:0030352) inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.2 | 1.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 0.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 1.8 | GO:0016594 | glycine binding(GO:0016594) |
0.2 | 0.5 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 0.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.2 | 0.2 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.2 | 0.8 | GO:0052724 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 1.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.2 | 0.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 0.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.3 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 0.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 0.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.6 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 1.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 1.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.6 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 2.0 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 2.0 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 2.0 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 2.0 | GO:0005267 | potassium channel activity(GO:0005267) |
0.1 | 1.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.3 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.6 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 2.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 1.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 3.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 3.6 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 1.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 2.9 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.4 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 5.8 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.7 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 2.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.3 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 0.5 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 1.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.5 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 2.8 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.1 | 0.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.1 | 0.3 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.1 | 0.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.4 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 1.4 | GO:0052736 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 4.4 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.3 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.7 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 1.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.7 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 1.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.8 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 1.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.8 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 2.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 5.4 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 0.9 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 1.7 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.3 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 1.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 2.2 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 0.1 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 0.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 1.4 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 1.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.4 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.2 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.8 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 1.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.5 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.8 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 1.0 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.0 | GO:0035410 | dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) |
0.0 | 3.2 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 1.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.7 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 1.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 2.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.1 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.8 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.4 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.0 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.0 | 0.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.1 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.2 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.0 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.6 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 7.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 10.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 9.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 10.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 6.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 5.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 5.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 0.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 14.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 1.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 3.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 6.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 2.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 1.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 3.5 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 2.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 3.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 1.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 3.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 2.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.0 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.1 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 2.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.8 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 1.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 13.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
1.0 | 14.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.9 | 1.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.7 | 8.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.7 | 4.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.7 | 9.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.6 | 16.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.6 | 9.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.6 | 7.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 3.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 7.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 3.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 4.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 1.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.4 | 5.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.4 | 7.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 4.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 17.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.4 | 5.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.4 | 11.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 8.3 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 2.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 3.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 2.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 0.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 5.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 0.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 6.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.3 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.3 | 3.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 4.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 3.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 1.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 0.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 3.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 1.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 3.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 1.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 4.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 2.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 0.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 1.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 2.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 2.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 1.5 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.2 | 2.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 1.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 2.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 3.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 1.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 1.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 2.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 1.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 1.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 1.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 3.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 1.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 0.6 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 3.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 1.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 1.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 1.4 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 2.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 2.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 6.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 1.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 2.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 1.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 3.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 3.1 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 2.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 4.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.9 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.2 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.1 | 1.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 0.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 0.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.9 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 1.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 0.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 3.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 1.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.0 | 0.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.0 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.0 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.0 | 0.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |